KALA BIO, Inc. (KALA)
NASDAQ: KALA · Real-Time Price · USD
5.74
-0.23 (-3.85%)
At close: Jul 18, 2025, 4:00 PM
5.69
-0.05 (-0.87%)
After-hours: Jul 18, 2025, 6:42 PM EDT
KALA BIO Market Cap
KALA BIO has a market cap or net worth of $37.04 million as of July 18, 2025. Its market cap has increased by 95.96% in one year.
Market Cap
37.04M
Enterprise Value
27.16M
1-Year Change
95.96%
Ranking
Category
Stock Price
$5.74
Market Cap Chart
Since July 20, 2017, KALA BIO's market cap has decreased from $430.50M to $37.04M, a decrease of -91.40%. That is a compound annual growth rate of -26.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 18, 2025 | 37.00M | 15.63% |
| Dec 31, 2024 | 32.00M | 69.31% |
| Dec 29, 2023 | 18.90M | -67.36% |
| Dec 30, 2022 | 57.90M | -26.99% |
| Dec 31, 2021 | 79.30M | -79.14% |
| Dec 31, 2020 | 380.20M | 198.20% |
| Dec 31, 2019 | 127.50M | -22.87% |
| Dec 31, 2018 | 165.30M | -63.54% |
| Dec 29, 2017 | 453.40M | 5.32% |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 708.25B |
| Johnson & Johnson | 392.89B |
| AbbVie | 336.66B |
| Novo Nordisk | 301.36B |
| UnitedHealth Group | 260.53B |
| Novartis AG | 233.75B |
| AstraZeneca | 217.77B |
| Abbott Laboratories | 214.35B |